Bạn đang xem bản rút gọn của tài liệu. Xem và tải ngay bản đầy đủ của tài liệu tại đây (90.55 KB, 3 trang )
Vitellineveins,457
Vocalcordparalysis,oralintakeand,1501
Volumeloading,atrioventricularseptaldefectsand,534
vonGierkedisease,cardiacinvolvementin,1087
W
Warfarin,1435–1436
inKawasakisyndrome,994–995
for“well”Fontan,1338
Water,retentionof,inchronicheartfailure,1198
Waterston'sgroove,19–20,21f
Wavereflection,1361
indexes,inarterialstiffness,1365–1366,1366f
Weaning,frommechanicalsupport,1190–1191
Weight,forinterstagemanagement,1307–1308
Weightgaingoals,1497t
“Well”Fontan,managementof,1336–1340
aldosteroneantagonistsin,1338–1339
angiotensin-convertingenzymeinhibitionin,1338–1339
birthcontrolfor,1339–1340,1339t
β-blockadein,1338–1339
exercisefor,1339
medicaltreatmentfor,1337–1338
practiceguidelines,roleof,1336–1337,1337f
WesternCanadianChildren'sHeartNetworkDatabase,1511t–1514t
Whitecoathypertension,1122
Whitematterinjury,incongenitalbraindisease,1396–1397
Williams-Beurensyndrome,838–839
Williamssyndrome,1412,1412f,1412t